The neurotransmitter glycine is removed from the synaptic cleft by two Na ؉ -and Cl ؊ -dependent transporters, the glial (GLYT1) and neuronal (GLYT2) glycine transporters. GLYT2 lacks a conserved cysteine in the first hydrophilic loop (EL1) that is reactive to [2-(trimethylammonium)ethyl] methanethiosulfonate (MTSET) in related transporters. A chimeric GLYT2 (GLYT2a-EL1) that contains GLYT1 sequences in this region, including the relevant cysteine, was sensitive to the reagent, and its sensitivity was decreased by co-substrates. We combined cysteine-specific biotinylation to detect transporter-reagent interactions with MTSET inactivation assays and temperature dependence analysis to study the mechanism by which Cl ؊ , Na ؉ , and glycine reduce methanethiosulfonate reagent inhibition. We demonstrate a Na ؉ protective effect rather than an increased susceptibility to the reagent exerted by Li ؉ , as reported for the serotonin transporter. The different inhibition, protection, and reactivation properties between GLYT2a-EL1 and serotonin transporter suggest that EL1 is a source of structural heterogeneity involved in the specific effect of lithium on serotonin transport. The protection by Na ؉ or Cl ؊ on GLYT2a-EL1 was clearly dependent on temperature, suggesting that EL1 is not involved in ion binding but is subjected to ion-induced conformational changes. Na ؉ and Cl ؊ were required for glycine protection, indicating the necessity of prior ion interaction with the transporter for the binding of glycine. We conclude that EL1 acts as a fluctuating hinge undergoing sequential conformational changes during the transport cycle.The role of glycine as an inhibitory neurotransmitter in the spinal cord and the brain stem of vertebrates is well established. There, it participates in the processing of motor and sensory information involved in several functions like movement, vision, and audition (1). Additionally, glycine exerts a positive modulation on the action of glutamate, the main excitatory neurotransmitter in the brain, through postsynaptic N-methyl-D-aspartate receptors. The re-uptake of glycine into presynaptic nerve terminals or surrounding glial processes plays a major role in the maintenance of low synaptic levels of the transmitter (2, 3). Glycine uptake is mediated by specific Na ϩ -and Cl Ϫ -dependent transporters that are members of the neurotransmitter transporter family (4 -7), a group of integral glycoproteins (8 -10) that share a common structure with 12 transmembrane domains (11). A new role for the glycine transporters as targets for future therapeutic drugs is now emerging. It has been demonstrated that hypofunction of glutamatergic (N-methyl-D-aspartate receptor-mediated) neurotransmission is involved in symptoms of schizophrenia (12). Because glycine is required for glutamate activation of N-methyl-D-aspartate receptors, this hypofunction could be relieved by inhibiting glycine transporters in the receptor surroundings. It is also likely that a decrease in the glycinergic inputs is involved in patho...